CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Common Stock [Member]	Common Stock Be Issued [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2022	$ 13	$ 336,000	$ 78,909,154	$ 39,141	$ (83,922,516)	$ (4,638,208)
Beginning balance, shares at Dec. 31, 2022	137,403
Stock issued for conversion of non-redeemable convertible notes	$ 4		121,696			121,700
Stock issued for conversion of non-redeemable convertible notes, shares	41,500
Stock issued for settlement of debt - related party	$ 1		274,792			274,793
Stock issued for settlement of debt - related party, shares	7,324
Stock issued for the conversion of Series B convertible preferred stock	$ 1		69,860			69,861
Stock issued for the conversion of Series B convertible preferred stock, shares	7,000
Foreign currency translation adjustment				(7,088)		(7,088)
Net loss					(505,484)	(505,484)
Ending balance, value at Mar. 31, 2023	$ 19	336,000	79,375,502	32,053	(84,428,000)	(4,684,426)
Ending balance, shares at Mar. 31, 2023	193,227
Beginning balance, value at Dec. 31, 2023	$ 4,210		89,278,354	6,270	(92,086,178)	(2,797,344)
Beginning balance, shares at Dec. 31, 2023	42,090,329
Stock issued for conversion of non-redeemable convertible notes	$ 5,865		450,135			456,000
Stock issued for conversion of non-redeemable convertible notes, shares	58,650,000
Stock issued for settlement of debt - related party	$ 800		295,200			296,000
Stock issued for settlement of debt - related party, shares	8,000,000
Foreign currency translation adjustment				27,834		27,834
Net loss					(782,146)	(782,146)
Ending balance, value at Mar. 31, 2024	$ 10,875		$ 90,023,689	$ 34,104	$ (92,868,324)	$ (2,799,656)
Ending balance, shares at Mar. 31, 2024	108,740,329